Increasing cardiovascular disease prevalence is fueling growth in the pacemaker market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Pacemakers Market Progress Between 2026 And 2030?

The pacemakers market size has demonstrated significant growth over recent years. It is anticipated to expand from $5.68 billion in 2025 to $6.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. The expansion seen in previous periods can be linked to factors such as limited access to diagnostic labs, a reliance on in-clinic testing, the increasing prevalence of chronic diseases, heightened health awareness, and the continued adoption of traditional testing methods.

The pacemakers market is anticipated to experience substantial expansion in the coming years. Projections indicate it will reach $8.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing acceptance of home healthcare, a rising need for personalized diagnostic solutions, the proliferation of rapid diagnostic technologies, the incorporation of tests with mobile applications and interconnected devices, and consumers’ growing inclination towards convenience and privacy. Significant trends expected within the forecast timeframe encompass a greater uptake of consumer self-testing kits, an escalating demand for diagnostics performed at home, the widespread availability of rapid diagnostic testing, heightened public understanding of preventive healthcare, and the merging of smart devices with over-the-counter tests.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6593&type=smp

What Major Factors Are Driving The Pacemakers Market Forward?

The increasing incidence of cardiovascular diseases is fueling the expansion of the pacemaker market going forward. Cardiovascular diseases are conditions that affect the heart and blood vessels. Drug discovery technologies are utilized to uncover new drugs for cardiovascular diseases. Pacemakers incorporate flexible and insulated wires that are effective in managing cardiovascular diseases by controlling irregular heart rhythms. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000, indicating a 4.0% rise from last year’s rate of 224.4 per 100,000, following a 4.6% increase in 2023, which marked the first increase in these rates observed in many years. Consequently, the rising prevalence of cardiovascular diseases will drive the growth of the pacemaker market.

How Are Segments Identified Within The Pacemakers Market Segment Framework?

The pacemakers market covered in this report is segmented –

1) By Type: MRI Compatible Pacemaker, Conventional Pacemaker

2) By Technology: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Or CRT Pacemaker

3) By Implantability: Implantable Pacemaker, External Pacemaker

4) By Application: Congestive Heart Failure, Arrhythmias, Bradycardia, Tachycardia

5) By End-User: Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By MRI Compatible Pacemaker: Single-Chamber MRI Compatible Pacemaker, Dual-Chamber MRI Compatible Pacemaker, Biventricular MRI Compatible Pacemaker

2) By Conventional Pacemaker: Single-Chamber Conventional Pacemaker, Dual-Chamber Conventional Pacemaker, Biventricular Conventional Pacemaker

Which Trends Are Impacting The Progress Of The Pacemakers Market?

Major companies in the pacemaker market are developing innovative products such as miniaturized pacemakers to reach wider customer bases, increase sales, and boost revenue. These miniaturized pacemakers are highly compact cardiac implantable electronic devices (CIEDs) designed to regulate heart rhythm and treat specific heart rhythm disorders without using electrical leads or wires. For instance, in May 2023, Medtronic plc, a US-based medical device company, announced the U.S. Food and Drug Administration (FDA) approval for the Micra AV2 and Micra VR2, two miniaturized, leadless pacemakers. Recognized as the world’s smallest pacemakers, the Micra AV2 and Micra VR2 offer extended battery life and simplified programming compared to their predecessors. These leadless pacemakers continue to provide the benefits of reduced complications when compared to traditional pacemakers. With an impressive approximately 40% increase in battery life over earlier versions, the projected median battery life for the Micra AV2 and Micra VR2 is nearly 16 and 17 years, respectively. This implies that over 80% of patients who receive a Micra pacemaker are expected to require only one device for their lifetime. Moreover, the new Micra AV2 incorporates advanced algorithms that autonomously program AV synchrony, ensuring the coordination of the heart’s upper and lower chambers.

Who Are The Companies Competing Within The Pacemakers Market?

Major companies operating in the pacemakers market are Boston Scientific Corporation, Medtronic plc, Biotronik SE & Co KG, MicroPort Scientific Corporation, Shree Pacetronix Ltd, Oscor Inc, Osypka Medical GmbH, Abbott Laboratories, Lepu Medical Technology Beijing Co Ltd, Vitatron Holding BV, Pacetronix Limited, Sorin Group Italia SRL, CCC Medical Devices, Cardioelectronica, Izhevsky Mekhanichesky Zavod, Neuroiz, St Jude Medical (Abbott), Medico Spa, Braile Biomedica, Cardiaccs ApS, Hunan Huacheng Medical, Progetti SRL, Nihon Kohden Corporation, Schiller AG, Koninklijke Philips NV, Stryker Corporation, Physio Control Inc, AliveCor Inc.

Get The Full Pacemakers Market Report:

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Which Region Represents The Largest Share Of The Pacemakers Market?

North America was the largest region in the pacemaker market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pacemakers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pacemakers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Browse Through More Reports Similar to the Global Pacemakers Market 2026, By The Business Research Company

Oxygen Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oxygen-therapy-global-market-report

Aromatherapy Market Report

https://www.thebusinessresearchcompany.com/report/aromatherapy-global-market-report

Convalescent Plasma Therapy Market Report

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795